These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 24173639)
1. Bioactive activities of natural products against herpesvirus infection. Son M; Lee M; Sung GH; Lee T; Shin YS; Cho H; Lieberman PM; Kang H J Microbiol; 2013 Oct; 51(5):545-51. PubMed ID: 24173639 [TBL] [Abstract][Full Text] [Related]
2. Natural Products and Their Derivatives against Human Herpesvirus Infection. Ruchawapol C; Yuan M; Wang SM; Fu WW; Xu HX Molecules; 2021 Oct; 26(20):. PubMed ID: 34684870 [TBL] [Abstract][Full Text] [Related]
8. Synergistic inhibition of herpesvirus replication by docosanol and antiviral nucleoside analogs. Marcelletti JF Antiviral Res; 2002 Nov; 56(2):153-66. PubMed ID: 12367721 [TBL] [Abstract][Full Text] [Related]
9. Two-Metal Ion-Dependent Enzymes as Potential Antiviral Targets in Human Herpesviruses. DiScipio KA; Weerasooriya S; Szczepaniak R; Hazeen A; Wright LR; Wright DL; Weller SK mBio; 2022 Feb; 13(1):e0322621. PubMed ID: 35073739 [TBL] [Abstract][Full Text] [Related]
10. DNA encapsidation as a target for anti-herpesvirus drug therapy. Visalli RJ; van Zeijl M Antiviral Res; 2003 Jul; 59(2):73-87. PubMed ID: 12895691 [TBL] [Abstract][Full Text] [Related]
11. The role of PI3K/Akt in human herpesvirus infection: From the bench to the bedside. Liu X; Cohen JI Virology; 2015 May; 479-480():568-77. PubMed ID: 25798530 [TBL] [Abstract][Full Text] [Related]
12. Thymidine kinase and protein kinase in drug-resistant herpesviruses: Heads of a Lernaean Hydra. Topalis D; Gillemot S; Snoeck R; Andrei G Drug Resist Updat; 2018 Mar; 37():1-16. PubMed ID: 29548479 [TBL] [Abstract][Full Text] [Related]
13. Targeting Host Cellular Factors as a Strategy of Therapeutic Intervention for Herpesvirus Infections. Asha K; Sharma-Walia N Front Cell Infect Microbiol; 2021; 11():603309. PubMed ID: 33816328 [TBL] [Abstract][Full Text] [Related]
14. Management of herpesvirus infections. Evans CM; Kudesia G; McKendrick M Int J Antimicrob Agents; 2013 Aug; 42(2):119-28. PubMed ID: 23820015 [TBL] [Abstract][Full Text] [Related]
15. Small RNAs growing tall: miRNAs as drug targets in herpesvirus infections. L'Hernault A; Dölken L Curr Opin Virol; 2015 Dec; 15():41-7. PubMed ID: 26256575 [TBL] [Abstract][Full Text] [Related]
16. Resistance of herpesviruses to antiviral drugs: clinical impacts and molecular mechanisms. Gilbert C; Bestman-Smith J; Boivin G Drug Resist Updat; 2002 Apr; 5(2):88-114. PubMed ID: 12135584 [TBL] [Abstract][Full Text] [Related]
17. Profile of anti-herpetic action of ASP2151 (amenamevir) as a helicase-primase inhibitor. Yajima M; Yamada H; Takemoto M; Daikoku T; Yoshida Y; Long T; Okuda T; Shiraki K Antiviral Res; 2017 Mar; 139():95-101. PubMed ID: 28027917 [TBL] [Abstract][Full Text] [Related]
18. The DNA helicase-primase complex as a target for herpes viral infection. Weller SK; Kuchta RD Expert Opin Ther Targets; 2013 Oct; 17(10):1119-32. PubMed ID: 23930666 [TBL] [Abstract][Full Text] [Related]
19. Berberine in Human Oncogenic Herpesvirus Infections and Their Linked Cancers. Šudomová M; Berchová-Bímová K; Marzocco S; Liskova A; Kubatka P; Hassan STS Viruses; 2021 May; 13(6):. PubMed ID: 34071559 [TBL] [Abstract][Full Text] [Related]
20. [Mechanisms of antiviral resistance among the herpesvirus group]. Reina J Enferm Infecc Microbiol Clin; 1997; 15(6):329-34. PubMed ID: 9376408 [No Abstract] [Full Text] [Related] [Next] [New Search]